These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 32641700)

  • 1. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
    Song JW; Zhang C; Fan X; Meng FP; Xu Z; Xia P; Cao WJ; Yang T; Dai XP; Wang SY; Xu RN; Jiang TJ; Li WG; Zhang DW; Zhao P; Shi M; Agrati C; Ippolito G; Maeurer M; Zumla A; Wang FS; Zhang JY
    Nat Commun; 2020 Jul; 11(1):3410. PubMed ID: 32641700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 pneumonia: CD8
    Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
    Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune characteristics of severe and critical COVID-19 patients.
    Yang L; Gou J; Gao J; Huang L; Zhu Z; Ji S; Liu H; Xing L; Yao M; Zhang Y
    Signal Transduct Target Ther; 2020 Aug; 5(1):179. PubMed ID: 32868756
    [No Abstract]   [Full Text] [Related]  

  • 7. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
    De Biasi S; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Gozzi L; Iannone A; Lo Tartaro D; Mattioli M; Paolini A; Menozzi M; Milić J; Franceschi G; Fantini R; Tonelli R; Sita M; Sarti M; Trenti T; Brugioni L; Cicchetti L; Facchinetti F; Pietrangelo A; Clini E; Girardis M; Guaraldi G; Mussini C; Cossarizza A
    Nat Commun; 2020 Jul; 11(1):3434. PubMed ID: 32632085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
    Agrati C; Sacchi A; Bordoni V; Cimini E; Notari S; Grassi G; Casetti R; Tartaglia E; Lalle E; D'Abramo A; Castilletti C; Marchioni L; Shi Y; Mariano A; Song JW; Zhang JY; Wang FS; Zhang C; Fimia GM; Capobianchi MR; Piacentini M; Antinori A; Nicastri E; Maeurer M; Zumla A; Ippolito G
    Cell Death Differ; 2020 Nov; 27(11):3196-3207. PubMed ID: 32514047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune dysfunction following COVID-19, especially in severe patients.
    Song CY; Xu J; He JQ; Lu YQ
    Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
    Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2020; 11():1870. PubMed ID: 32983106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell landscape of immunological responses in patients with COVID-19.
    Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
    Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
    Mazzoni A; Salvati L; Maggi L; Capone M; Vanni A; Spinicci M; Mencarini J; Caporale R; Peruzzi B; Antonelli A; Trotta M; Zammarchi L; Ciani L; Gori L; Lazzeri C; Matucci A; Vultaggio A; Rossi O; Almerigogna F; Parronchi P; Fontanari P; Lavorini F; Peris A; Rossolini GM; Bartoloni A; Romagnani S; Liotta F; Annunziato F; Cosmi L
    J Clin Invest; 2020 Sep; 130(9):4694-4703. PubMed ID: 32463803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Cytotoxic CD8
    Westmeier J; Paniskaki K; Karaköse Z; Werner T; Sutter K; Dolff S; Overbeck M; Limmer A; Liu J; Zheng X; Brenner T; Berger MM; Witzke O; Trilling M; Lu M; Yang D; Babel N; Westhoff T; Dittmer U; Zelinskyy G
    mBio; 2020 Sep; 11(5):. PubMed ID: 32948688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological features of coronavirus disease 2019 in patients with cancer.
    Thibaudin M; Fumet JD; Bon M; Hampe L; Limagne E; Ghiringhelli F
    Eur J Cancer; 2020 Nov; 139():70-80. PubMed ID: 32977223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
    Rydyznski Moderbacher C; Ramirez SI; Dan JM; Grifoni A; Hastie KM; Weiskopf D; Belanger S; Abbott RK; Kim C; Choi J; Kato Y; Crotty EG; Kim C; Rawlings SA; Mateus J; Tse LPV; Frazier A; Baric R; Peters B; Greenbaum J; Ollmann Saphire E; Smith DM; Sette A; Crotty S
    Cell; 2020 Nov; 183(4):996-1012.e19. PubMed ID: 33010815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemically comparing host immunity between survived and deceased COVID-19 patients.
    Wang F; Hou H; Yao Y; Wu S; Huang M; Ran X; Zhou H; Liu Z; Sun Z
    Cell Mol Immunol; 2020 Aug; 17(8):875-877. PubMed ID: 32541836
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
    Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
    Han M; Xu M; Zhang Y; Liu Z; Li S; He T; Li J; Gao Y; Liu W; Li T; Chen Z; Huang X; Cheng G; Wang J; Dittmer U; Witzke O; Zou G; Li X; Lu M; Zhang Z
    Med Microbiol Immunol; 2020 Dec; 209(6):657-668. PubMed ID: 32860073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.